Identification of direct target engagement biomarkers for kinase-targeted therapeutics.
Pharmacodynamic (PD) biomarkers are an increasingly valuable tool for decision-making and prioritization of lead compounds during preclinical and clinical studies as they link drug-target inhibition in cells with biological activity. They are of particular importance for novel, first-in-class mechan...
Main Authors: | Cloud P Paweletz, Jannik N Andersen, Roy Pollock, Kumiko Nagashima, Mansuo L Hayashi, Shangshuan U Yu, Hongbo Guo, Ekaterina V Bobkova, Zangwei Xu, Alan Northrup, Peter Blume-Jensen, Ronald C Hendrickson, An Chi |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3200335?pdf=render |
Similar Items
-
Resistance to kinase inhibition through shortened target engagement
by: Aziz M. Rangwala, et al.
Published: (2022-12-01) -
Discovery and translation of a target engagement marker for AMP-activated protein kinase (AMPK).
by: Rolf Grempler, et al.
Published: (2018-01-01) -
Targeting kinases with precision
by: Alexandra K. Gardino, et al.
Published: (2018-05-01) -
A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors
by: Paweletz Cloud, et al.
Published: (2010-06-01) -
Cellular proteins as potential targets for antiretroviral therapy
by: Marina R. Bobkova
Published: (2023-12-01)